Given that both drugs look 100% toast, I rate the chance of this meeting simply not being rescheduled as about 80%
How common it is to have 2 such statistically crappy NDAs up on the same day?
To be honest, I thought the CTIC meeting would be more to discourse a forward path to a trial that could actually help on the cardio issue (which is a tough issue trial wise). After reading the FDA brief, I think it was to put a knife in.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.